Healthcare research from Bristol Myers Squibb, page 2
A filtered view. Show the full list.
Refine
Listings
-
ArticleNature communications
Single-cell atlas of human lung aging identifies cell type dyssynchrony and increased transcriptional entropy
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Research dataAdded
-
ArticleNature
Identification of an allosteric site on the E3 ligase adapter cereblon
Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, GSK. Affiliation source
-
ReviewNPJ digital medicine
Machine learning models for drug-drug interaction prediction from computational discovery to clinical application
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
-
Clinical trial reportThe New England journal of medicine
Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticleCurrent medical research and opinion
Plain language summary looking at the impact of increased patient out-of-pocket costs on stopping oral anticoagulant treatment among Medicare beneficiaries with atrial fibrillation treated with apixaban
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Public healthAdded
-
ArticleCurrent medical research and opinion
Cost comparison between apixaban and low molecular weight heparin (LMWH) among venous thromboembolism (VTE) patients with cancer
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticlePersonalized medicine
Toward a harmonized assessment of MRD by NGS: blinded pilot study of NGS assays by MPAACT consortium
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticleBioanalysis
2025 White Paper on Recent Issues in Bioanalysis: Redosing Patients with AAV Gene Therapy; CRS Immunogenicity Risk; Shedding Assays; NHP Studies Immunogenicity; CMC vs Bioanalytical Assays; Artificial Intelligence-Powered Genomic Pipelines for NGS (PART 3A - Recommendations on Gene, Cell, and Vaccine Therapies Immunogenicity & Technologies; Biotherapeutics & Biosimilars Immunogenicity Assessment & Clinical Relevance PART 3B - Regulatory Agencies' Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies)
Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, GSK. Affiliation source
-
ArticleBioanalysis
2025 White Paper on Recent Issues in Bioanalysis: Biomarkers Calibrators & Stability; Evaluation of NULISA; Neurofilament & Autoantibody Biomarker Assays; Removing IgM Interference; ELISpot & FluoroSpot Best Practices; Modular HD Cytometry; Single-cell Analysis Imaging Cytometry (PART 2A - Recommendations on Biomarkers Discovery, Development, Validation & Regulatory Approval, Ligand-Binding Assays (LBA) and Cell-Based Assays (CBA) PART 2B - Regulatory Agencies' Input on Biomarkers, IVD/CDx and Biomarker Assay Validation (BAV))
Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, GSK, Johnson & Johnson. Affiliation source
-
ArticleBiometrics
TITE-safety: a robust time-to-event safety monitoring approach for clinical trials
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticleInternational journal of surgery (London, England)
Decoding hepatocellular carcinoma prognosis: a machine learning-derived methylation signature integrating transcriptomic and tumor microenvironment insights
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Disease researchAdded
-
ArticleBMJ oncology
Efficacy of nivolumab plus relatlimab versus BRAF/MEK inhibitors for first-line treatment of BRAF-mutant advanced melanoma: A matching-adjusted indirect comparison
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
Clinical trial reportJournal for immunotherapy of cancer
Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancer
Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, Thomas Jefferson University. Affiliation source
Clinical careAdded
-
ArticleCancer immunology research
The Presence of CD11c+ B Cells with Potent Effector Memory Phenotype in Lung Adenocarcinoma Correlates with Overall Patient Survival
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Disease researchAdded
-
ArticleCirculation. Heart failure
Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Adverse Outcomes in Heart Failure
Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, Hospital of the University of Pennsylvania, with Penn Medicine linked by the institution reference. Affiliation source
Disease researchAdded
-
Clinical trial reportJournal of the American Heart Association
Ex Vivo Effect of Apixaban on Hemostatic Biomarkers in Children With Heart Disease: A SAXOPHONE Trial Substudy
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Disease researchAdded
-
ArticleJournal of the American Heart Association
Clinical Impact of Switching From or Persisting With Rivaroxaban or Apixaban After a Bleeding Event: A Real-World Study in Patients With Nonvalvular Atrial Fibrillation
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticleThe American journal of sports medicine
Comparing 10-Year Follow-up Outcomes Among Patients Without Unstable Chondral Lesions Versus Those With Unstable Chondral Lesions (Left In Situ) at the Time of Arthroscopic Partial Meniscectomy
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
ArticleJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Impact of social determinants of health on treatment patterns and outcomes in metastatic non-small cell lung cancer
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Public healthAdded
-
ArticleJCO precision oncology
Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based Circulating Tumor DNA Assays, Version 2.0
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
-
ReviewThe AAPS journal
HLA Class II Alleles DRB1*11:01 and DQB1*03:01 Unmask Immunogenetic Susceptibility to Anti-Nivolumab Antibodies in Combination with Ipilimumab
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Disease researchAdded
-
ArticleThe AAPS journal
Updated Recommendations for the Bioanalysis of Antibody-Drug Conjugates (ADC) from the ADC working group of the AAPS Bioanalytical Community
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
-
ArticleJournal of comparative effectiveness research
Development and validation of a method to compare outcomes between switchers and continuers in routine clinical practice
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
Clinical careAdded
-
Clinical trial reportJAMA cardiology
Effects of Mavacamten on Measures of Cardiopulmonary Exercise Testing Beyond Peak Oxygen Consumption: A Secondary Analysis of the EXPLORER-HCM Randomized Trial
Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, Perelman School of Medicine, University of Pennsylvania. Affiliation source
Clinical careAdded